For the Inventor, By the Inventor

Enter inventor name

Cincinnati, OH, United States of America

Kevin Gene Peters

USPTO Granted Patents = 34 (Patent Applications = 38)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 19)

Average Co-Inventor Count = 1.6

ph-index = 13

Forward Citations = 427(Granted Patents)

Company Filing History:

Aerpio Therapeutics, Inc.

Eyepoint Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc.

Aeripo Therapeutics Inc.

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398204 - Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist (2025-08-26),

2. 12171751 - Methods of treating intraocular pressure with activators of Tie-2 (2024-12-24),

3. 12152023 - Compositions, formulations and methods for treating ocular diseases (2024-11-26),

4. 12145986 - Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta) (2024-11-19),

5. 12064420 - Tie-2 activators targeting the Schlemm's canal (2024-08-20),

6. 12043664 - Methods for treating vascular leak syndrome and cancer (2024-07-23),

7. 11873334 - Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF (2024-01-16),

8. 11814425 - Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof (2023-11-14),

9. 11666558 - Methods of treating intraocular pressure with activators of Tie-2 (2023-06-06),

10. 11413242 - Formulations of Tie-2 activators and methods of use thereof (2022-08-16),

11. 11253502 - Tie-2 activators targeting the Schlemm's canal (2022-02-22),

12. 11180551 - Humanized monoclonal antibodies that target VE-PTP (HPTP-beta) (2021-11-23),

13. 11136389 - Humanized monoclonal antibodies that target VE-PTP (HPTP-β) (2021-10-05),

14. 10952992 - Methods of treating intraocular pressure with activators of Tie-2 (2021-03-23),

15. 10894824 - Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF (2021-01-19),

Title: Kevin Gene Peters - Innovative Inventor from Cincinnati

Introduction: Kevin Gene Peters is a talented inventor based in Cincinnati, Ohio, known for his groundbreaking contributions to various industries.

Latest Patents: Kevin Gene Peters holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Kevin Gene Peters has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Kevin Gene Peters has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Kevin Gene Peters continues to push the boundaries of innovation, and his passion for creating impactful solutions is evident in his impressive body of work.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…